News Image

Tonix Pharmaceuticals Announces FDA Approval of Tonmyaâ„¢ (cyclobenzaprine HCl sublingual tablets) for the Treatment of Fibromyalgia

Provided By GlobeNewswire

Last update: Aug 15, 2025

Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in over 15 years

Fibromyalgia is a chronic pain condition that affects more than 10 million adults in the U.S. who are mostly women

Read more at globenewswire.com

TONIX PHARMACEUTICALS HOLDIN

NASDAQ:TNXP (10/2/2025, 7:02:41 PM)

After market: 24.55 -0.17 (-0.69%)

24.72

+0.77 (+3.22%)



Find more stocks in the Stock Screener

Follow ChartMill for more